Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased levels of antivirals
Drug 1
Drug 1 effect
No significant change
Drug 2
Drug 2 effect
Elbasvir Cmax increased 91%, AUC increased 118%; Grazoprevir Cmax increased 359%, AUC increased436%
Clinical Effects
Potential for increased AUC of HCV agents
Management
Use alternative agents
Import ID
187
